Market Analysis and Insights:
The market for Global Transcatheter Embolization Devices was estimated to be worth USD XX billion in 2021, and from 2021 to 2031, it is anticipated to grow at a CAGR of XX%, with an expected value of USD XX billion in 2031.
The surge in demand for transcatheter embolization devices is propelled by various significant factors. To begin with, the escalating prevalence of chronic ailments, including cancer, liver tumors, and uterine fibroids, has spurred the need for less invasive treatment alternatives, thereby fostering market expansion. Furthermore, advancements in device technology, such as the introduction of bioresorbable embolic agents and innovative catheter systems, have augmented the effectiveness and safety of these devices, driving further growth in the market. Additionally, the global increase in aging populations and the corresponding uptick in age-related illnesses have led to a ened adoption of transcatheter embolization procedures. The compelling advantages offered by these devices, such as reduced hospital stay, quicker recovery times, and minimal post-operative issues, have incentivized patients to choose these procedures, consequently propelling market progression.
Lastly, favorable reimbursement schemes for transcatheter embolization devices and the escalating investments by key industry players in research and development endeavors are poised to amplify market growth in the foreseeable future.
Transcatheter Embolization Devices Market Scope:
| Metrics | Details |
| Base Year | 2023 |
| Historic Data | 2018-2022 |
| Forecast Period | 2024-2031 |
| Study Period | 2018-2031 |
| Forecast Unit | Value (USD) |
| Revenue forecast in 2031 | USD XX billion |
| Growth Rate | CAGR of XX% during 2021-2031 |
| Segment Covered | By Type, By Application, By Material, By Coil Type, By End-User, By Embolization Particles Type, By Region. |
| Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
| Key Players Profiled | Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Stryker Corporation, Johnson & Johnson, Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., and Abbott Laboratories. |
Market Definition
Transcatheter embolization devices represent advanced medical tools employed to obstruct or restrict the circulation of blood to a precise anatomical region through a minimally invasive technique, commonly utilizing a catheter. Their primary purpose is to address a range of medical issues including hemorrhaging, neoplasms, or abnormalities in blood vessels.
Transcatheter embolization devices are pivotal tools in the realm of interventional radiology, serving a vital role in the treatment of a diverse array of medical conditions. These devices offer a minimally invasive approach as an alternative to surgical interventions in a variety of scenarios, including the management of bleeding, occlusion of blood supply to tumors, treatment of aneurysms, and the control of select vascular abnormalities. Through the utilization of a catheter to reach the specific target area, healthcare providers can precisely administer embolic agents like coils, particles, or other substances to impede or minimize blood flow, thereby achieving the intended therapeutic effect. Beyond delivering less invasive treatment modalities for patients, transcatheter embolization devices contribute to reduced recovery periods and lower rates of complications when juxtaposed with conventional surgical methods. Ultimately, the significance of transcatheter embolization devices resides in their capacity to elevate patient outcomes and advance the field of interventional radiology.
Key Market Segmentation:
Insights On Key Type
Flow Diverter Devices
The Flow Diverter Devices is expected to dominate the Global Transcatheter Embolization Devices Market. Flow diverter devices are becoming increasingly popular in the market due to their ability to treat complex intracranial aneurysms. These devices are designed to divert blood flow away from the aneurysm, promoting healing and preventing rupture. With the rising prevalence of intracranial aneurysms and the growing demand for minimally invasive treatment options, the demand for flow diverter devices is expected to surge. Additionally, advancements in technology and product innovation within this part further contribute to its dominance in the market.
Embolization Coils
Embolization coils are another important devices within the Global Transcatheter Embolization Devices Market. These coils are used to block blood flow within blood vessels, resulting in the formation of blood clots and the occlusion of targeted vessels. While not expected to dominate the market, embolization coils continue to play a significant role in the treatment of various conditions such as arteriovenous malformations, aneurysms, and uterine fibroids. The market for embolization coils is driven by the increasing prevalence of these conditions and the effectiveness of coil embolization procedures in achieving successful outcomes.
Coiling-assist Devices
Coiling-assist devices are designed to aid in the precise placement and delivery of embolization coils within blood vessels. These devices act as complementary tools to embolization coils, enhancing their effectiveness and ensuring accurate positioning during procedures. While not anticipated to dominate the market, coiling-assist devices contribute to the overall growth of the Global Transcatheter Embolization Devices Market by facilitating safer and more efficient coil embolization procedures.
Embolization Particles
Embolization particles are tiny spheres or granules used to achieve selective occlusion of blood vessels. These particles are typically made of biocompatible materials and can be delivered through catheters to targeted areas. Although embolization particles have their applications and advantages in specific cases, they are not expected to dominate the Global Transcatheter Embolization Devices Market. Their usage is generally limited to certain conditions where particle embolization is more suitable than coil embolization or other techniques.
Liquid Embolics
Liquid embolics are liquid-based substances used for embolization procedures, primarily in the treatment of arteriovenous malformations and uterine fibroids. These embolics solidify upon contact with blood, resulting in vessel occlusion. While liquid embolics have their niche applications, they are not projected to dominate the Global Transcatheter Embolization Devices Market. Their utilization is more specific, and their demand is dependent on the prevalence of conditions that necessitate liquid embolization.
Accessories
Accessories in the Global Transcatheter Embolization Devices Market encompass a wide range of ancillary tools and devices required for successful embolization procedures. These may include catheters, guidewires, microcatheters, and other supporting devices. While essential for the overall performance and success of embolization procedures, accessories do not constitute a dominating part of the market. Their demand is directly linked to the adoption and utilization of primary embolization devices such as coils, flow diverters, particles, and liquid embolics.
Insights On Key Application
Neurology
The Neurology application is expected to dominate the Global Transcatheter Embolization Devices Market. Neurology involves the treatment of various neurological conditions such as arteriovenous malformations (AVMs), intracranial hemorrhages, and aneurysms. These conditions require precise embolization procedures to achieve successful outcomes. With advancements in technology and an increasing prevalence of neurological disorders, the demand for transcatheter embolization devices in Neurology is projected to be the highest.
Peripheral Vascular Disease
The Peripheral Vascular Disease application, although not dominating the market, is anticipated to hold a significant share in the Global Transcatheter Embolization Devices Market. Peripheral Vascular Disease refers to the narrowing or blockage of blood vessels outside the heart and brain. Transcatheter embolization devices are used in the treatment of conditions such as peripheral artery disease and varicoceles. Despite facing competition from other parts, the rising prevalence of vascular diseases and the development of innovative embolization devices will propel the growth of this part.
Oncology
The Oncology application of the Global Transcatheter Embolization Devices Market is projected to experience steady growth, albeit not dominating the market. Transcatheter embolization is utilized in the treatment of liver tumors, renal cell carcinoma, and other malignancies. While the demand for embolization devices in oncology is increasing due to the rising incidence of cancer, other parts such as Neurology might have a larger market share due to a wider range of conditions requiring treatment.
Urology
In the Global Transcatheter Embolization Devices Market, the Urology application is expected to have the least dominance among the discussed options. Urological conditions such as benign prostatic hyperplasia and renal artery embolization require transcatheter embolization as a treatment method. However, compared to other parts like Neurology and Peripheral Vascular Disease, the demand for embolization devices in Urology is relatively lower, resulting in a smaller market share. Nonetheless, advancements in urological embolization techniques may contribute to the growth of this part in the future.
Insights On Key Material
Particle Embolic
Particle embolic is expected to dominate the Global Transcatheter Embolization Devices Market. This is due to its wide range of applications and effectiveness in blocking blood vessels. The use of particle embolic agents, such as microspheres or microparticles, allows for targeted embolization, minimizing the risk of embolizing healthy tissues. Additionally, particle embolic offers a longer-lasting occlusion compared to other materials, providing better control over blood flow. Its versatility makes it the preferred choice for various procedures, including the treatment of arteriovenous malformations, uterine fibroids, and liver tumors.
Coil Embolic
Coil embolic is another important material, but it is not expected to dominate the Global Transcatheter Embolization Devices Market. Coil embolic agents are typically used in the treatment of intracranial aneurysms and peripheral artery embolization. While effective in specific applications, coil embolic has more limited uses compared to particle embolic. Its use is primarily focused on vascular structures, where the coil is placed to provoke thrombosis and block blood flow. However, due to its narrower scope of application, coil embolic is expected to have a smaller market share compared to particle embolic.
Liquid Embolic
Liquid embolic is yet another part within the Global Transcatheter Embolization Devices Market. It involves the use of liquid agents, such as ethylene-vinyl alcohol copolymer, to achieve embolization. Although liquid embolic has its merits, such as its ability to penetrate intricate vascular networks, it is not expected to dominate the market. Liquid embolic is primarily employed in the treatment of arteriovenous malformations, aneurysms, and vascular tumors. However, due to its specific applications and the availability of alternative materials like particle and coil embolic, the market share of liquid embolic is likely to be lower.
Others
The Others category refers to any other materials used in transcatheter embolization devices that are not specifically categorized under particle, coil, or liquid embolic. This part includes materials such as gelatin sponge, polyvinyl alcohol foam, and fibrin glue. While each of these materials has its unique properties and applications, they are not expected to dominate the Global Transcatheter Embolization Devices Market. The market share of this part is anticipated to be relatively smaller compared to particle embolic, as particle embolic offers a broader range of applications and advantages in terms of targeted embolization and longer-lasting occlusion.
Insights On Key Coil Type
Detachable
Detachable is expected to dominate the Global Transcatheter Embolization Devices Market. Detachable coil type offers several advantages over the pushable coil type. Detachable coils allow for precise positioning and controlled detachment, resulting in more effective embolization and reduced risks of migration or displacement. The ability to detach the coil from the delivery system also provides the flexibility to retreat or reposition if needed. Detachable coils are widely used in various embolization procedures, including the treatment of aneurysms and arteriovenous malformations. With advancements in technology and increasing adoption by healthcare professionals, the detachable coil type is expected to be the dominating part in the Global Transcatheter Embolization Devices Market.
Pushable
Pushable coil type, on the other hand, may be a viable option in some cases but is not expected to dominate the market. Pushable coils require manual detachment from the delivery system, which can be time-consuming and less precise compared to detachable coils. Pushable coils are typically used in cases where precise positioning is less critical, such as in the treatment of smaller vessels or peripheral vasculature. While pushable coils may still have a role in certain embolization procedures, their usage is generally limited compared to detachable coils.
Insights On Key End-User
Hospitals
Hospitals are expected to dominate the Global Transcatheter Embolization Devices Market. This is due to several factors. Firstly, hospitals tend to have a larger patient volume compared to other healthcare facilities, providing increased opportunities for the utilization of transcatheter embolization devices. Additionally, hospitals often have a wide range of specialized departments and healthcare professionals, including interventional radiologists and vascular surgeons, who are skilled in performing these procedures.
Ambulatory Surgical Centers
Ambulatory surgical centers are also an important end-user in the Global Transcatheter Embolization Devices Market. While they may not dominate the market as hospitals do, they play a significant role in providing outpatient surgical services, including transcatheter embolization procedures. Ambulatory surgical centers offer convenience and cost-effectiveness for patients, as well as advanced technology for performing minimally invasive interventions.
Clinics
Clinics represent another end-user in the Global Transcatheter Embolization Devices Market. Although clinics serve as important primary care facilities, their contribution to the transcatheter embolization devices market is relatively small compared to hospitals and ambulatory surgical centers. Clinics may refer patients to hospitals or ambulatory surgical centers for more specialized procedures, including transcatheter embolization.
Insights On Key Embolization Particles Type
Microspheres
Microspheres are expected to dominate the global Transcatheter Embolization Devices market. The increasing prevalence of liver cancer and liver metastasis, for which microspheres are commonly used, is one of the key factors driving the dominance of this part. Microspheres are tiny particles that can be loaded with radioactive isotopes or chemotherapeutic agents and delivered directly to the target site via transcatheter embolization procedures. Their ability to precisely target tumors and deliver therapeutics locally has made them a preferred choice among clinicians. Moreover, advancements in microsphere technology, such as the development of radiopaque microspheres for better visualization during embolization procedures, further contribute to their dominance in the market.
Radioembolization Particles
Radioembolization particles hold a significant share of the global Transcatheter Embolization Devices market. These particles are typically comprised of glass or resin microspheres that are loaded with radioactive isotopes and used for the treatment of liver cancer. Radioembolization has gained popularity as a minimally invasive therapy that offers targeted radiation to tumors while sparing healthy tissues. The rise in the incidence of liver cancer, coupled with the increased preference for minimally invasive procedures, contributes to the dominance of this part. Additionally, ongoing research and development activities focusing on improving the efficacy and safety of radioembolization particles further support their market dominance.
Drug-eluting Beads
Drug-eluting beads are another important particle type in the global Transcatheter Embolization Devices market. These beads are typically loaded with chemotherapeutic agents and are used to selectively embolize vessels supplying tumors. The release of the drugs from the beads over an extended period ensures sustained local delivery, enhancing the therapeutic effect. The growing prevalence of hepatocellular carcinoma and liver metastasis drives the demand for drug-eluting beads. Additionally, advancements in bead technology, such as the development of biocompatible and biodegradable beads, contribute to their dominance in the market.
Others
The Others category includes alternative types of embolization particles apart from radioembolization particles, microspheres, and drug-eluting beads. Although this part might have certain niche applications, it is expected to have a smaller market share compared to the dominant parts. The dominance of microspheres, radioembolization particles, and drug-eluting beads can be attributed to their well-established efficacy, safety, and wide utilization in the treatment of various tumors. However, ongoing research and advancements in embolization technology may lead to newer parts within the "Others" category emerging as strong contenders in the future.
Insights on Regional Analysis:
Europe
Europe is expected to dominate the Global Transcatheter Embolization Devices market. This dominance can be attributed to several factors. Firstly, Europe has a well-established healthcare infrastructure, with advanced medical facilities and a high level of healthcare expenditure. This facilitates the adoption of innovative medical technologies, such as transcatheter embolization devices. Additionally, there is a growing prevalence of chronic diseases in Europe, including cardiovascular diseases, cancer, and liver diseases, which often require the use of transcatheter embolization devices in their treatment. Furthermore, Europe has a large geriatric population, which is more susceptible to these diseases and thereby drives the demand for such devices. Moreover, Europe has a favorable regulatory environment and a strong presence of key market players, contributing to the market dominance of transcatheter embolization devices in the region.
North America
North America is another significant market for transcatheter embolization devices. The region has a high incidence of chronic diseases and a well-developed healthcare infrastructure, making it a favorable market for advanced medical technologies. Additionally, the increasing prevalence of lifestyle-related diseases, such as obesity and diabetes, further drives the demand for transcatheter embolization devices in the region. Furthermore, North America has a strong presence of major medical device manufacturers and research institutes, contributing to the development and adoption of these devices. However, while North America remains a substantial market, it is expected to be slightly overshadowed by Europe in terms of market dominance.
Asia Pacific
Asia Pacific is experiencing rapid growth in the transcatheter embolization devices market. This can be attributed to several factors. Firstly, the region has a large patient pool, particularly with the increasing geriatric population and changing lifestyle patterns leading to a higher incidence of chronic diseases. This drives the demand for effective treatment options, such as transcatheter embolization devices. Additionally, the healthcare infrastructure in many countries in the Asia Pacific region, including China, India, and Japan, has been improving, enabling better access to advanced medical technologies. Moreover, the increasing healthcare expenditure and government initiatives to improve healthcare facilities further contribute to the growth of the market in this region.
Latin America
Latin America is also witnessing significant growth in the transcatheter embolization devices market. The region has a growing prevalence of chronic diseases, including cardiovascular diseases, cancer, and liver diseases. However, compared to other regions, the healthcare infrastructure in Latin America is still developing, which may pose challenges to the widespread adoption of these devices. Nevertheless, the increasing healthcare expenditure, improving healthcare facilities, and the presence of major market players expanding their operations in the region are expected to drive the market growth in Latin America.
Middle East & Africa
The Middle East & Africa region is expected to show moderate growth in the transcatheter embolization devices market. The healthcare infrastructure in many countries in this region is still developing, leading to challenges in the adoption of advanced medical technologies. However, the region has a growing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, which require the use of transcatheter embolization devices. The increasing healthcare expenditure, along with government initiatives to improve healthcare facilities, is expected to drive the market growth in the Middle East & Africa region. However, compared to other regions like Europe and North America, it is likely to have a smaller market share in terms of dominance.
Company Profiles:
Prominent contributors in the international transcatheter embolization devices sector are engaged in the creation and production of cutting-edge medical equipment employed in embolization interventions, thus driving progress and enhancing the availability of minimally invasive therapies for a range of medical ailments. These entities are pivotal in partnering with medical practitioners, executing clinical studies, and broadening their range of offerings to address the changing requirements of patients on a global scale.
Leading companies in the market for Transcatheter Embolization Devices comprise Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Stryker Corporation, Johnson & Johnson, Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., and Abbott Laboratories. These firms are actively involved in the research, production, and dissemination of transcatheter embolization devices that are utilized in treating various conditions, including tumors, aneurysms, and uterine fibroids.
Leveraging cutting-edge technologies and diversified product offerings, these primary entities play a pivotal role in propelling progress and ingenuity within the Transcatheter Embolization Devices sector, meeting the requirements of healthcare professionals and patients globally.
COVID-19 Impact and Market Status:
The global market for Transcatheter Embolization Devices has experienced a notable downturn in growth as a result of the Covid-19 pandemic, attributed to disruptions in supply chains and decreases in healthcare expenditures.
The global market for Transcatheter Embolization Devices has experienced a significant impact as a result of the COVID-19 pandemic. The imposition of lockdowns, restrictions on travel, and the practice of social distancing have had adverse effects on the healthcare sector overall. This has led to a decrease in patient visits and elective procedures, causing a reduction in the demand for transcatheter embolization devices. These devices are utilized for minimally invasive treatment of various conditions such as tumors, aneurysms, and vascular malformations. The decline in non-urgent surgeries during the pandemic has led to lower procedural volumes and decreased sales of these devices. Additionally, the financial strain on healthcare systems due to the rising costs associated with managing COVID-19 patients and the redirection of resources towards pandemic response has further impeded market expansion. Nonetheless, with the gradual improvement in the situation and the resumption of healthcare services to pre-pandemic levels, the transcatheter embolization devices market is anticipated to bounce back. This rebound will be propelled by the increasing prevalence of target diseases and the continual advancements in the design and technology of these devices.
Latest Trends and Innovation:
- In September 2020, Medtronic plc announced the launch of its Concerto™ 3D Detachable Coil System, a new transcatheter embolization device used in the treatment of patients with brain aneurysms.
- In November 2019, Sirtex Medical Limited, a subsidiary of China Grand Pharmaceutical and Healthcare Holdings, completed its acquisition of BTG plc, a company known for its innovative medical technology products including transcatheter embolization devices.
- In September 2019, Terumo Corporation, a global leader in medical technology, acquired Quirem Medical B.V., a Dutch company specializing in the development of innovative microspheres for the treatment of liver cancer, thus expanding its portfolio in the transcatheter embolization devices market.
- In May 2018, Johnson & Johnson Medical Devices Companies announced its acquisition of BTG plc, which brought BTG's comprehensive portfolio of transcatheter embolization devices under the Johnson & Johnson umbrella.
- In April 2017, Boston Scientific Corporation announced the FDA approval of its Embozene™ Color-Advanced Microspheres for the treatment of hypervascular tumors and arteriovenous malformations, further establishing its presence in the transcatheter embolization devices market.
- In February 2017, Cook Medical received CE Mark approval for its Zenith® Branch Endovascular Graft-Iliac Bifurcation (ZBIS™), an innovative device used in the treatment of aortic and iliac artery aneurysms. This marked a significant development in the field of transcatheter embolization devices.
Significant Growth Factors:
Factors propelling the Transcatheter Embolization Devices Market's expansion comprise the growing prevalence of target diseases and conditions, advancements in device technology, and the increasing adoption of minimally invasive procedures.
The market for transcatheter embolization devices is currently witnessing a notable upsurge propelled by various pivotal elements. Initially, the escalating incidence of chronic ailments like cancer and cardiovascular conditions is driving the need for minimally invasive and precisely targeted treatment alternatives. Transcatheter embolization devices, devised to obstruct or diminish blood flow to specific body areas, present a less intrusive substitute to conventional surgical interventions, resulting in swifter recovery periods and decreased healthcare expenditures. Subsequently, advancements in interventional radiology have spurred the creation of groundbreaking and efficient embolization devices. These devices, including embolic coils, liquid embolics, and particle embolics, furnish more accurate and focused treatment choices, culminating in enhanced patient results. Moreover, the burgeoning elderly populace globally is fostering market expansion since the elderly are more vulnerable to various chronic conditions necessitating embolization procedures. Furthermore, the mounting consciousness among patients and healthcare practitioners concerning the advantages of minimally invasive procedures is propelling the uptake of transcatheter embolization devices. Such procedures offer diminished pain, decreased risk of complications, and abbreviated hospital stays, fostering ened patient contentment.
Restraining Factors:
The growth of the Transcatheter Embolization Devices market is hindered by the scarcity of experienced professionals and the significant procedural expenses.
The market for transcatheter embolization devices is anticipated to experience significant growth in the foreseeable future, propelled by factors such as the rising prevalence of conditions necessitating embolization procedures and innovations in minimally invasive techniques. Nevertheless, certain factors could impede market expansion. Firstly, the high expenses linked with transcatheter embolization devices could restrict their uptake, particularly in less developed regions. Secondly, the shortage of proficient professionals capable of effectively handling these devices might present challenges in ensuring the safety and efficacy of procedures. Additionally, the stringent regulatory environment and protracted approval processes for novel devices may defer their market entry and decelerate overall market progress. Furthermore, the potential risks of complications and adverse events associated with transcatheter embolization procedures may dissuade patients from choosing these therapies. Notwithstanding these obstacles, the Transcatheter Embolization Devices Market harbors substantial growth prospects, with manufacturers actively investing in research and development initiatives to create more economical devices with enhanced safety attributes.
Moreover, the escalating emphasis on educational programs and partnerships between healthcare providers and device manufacturers can help mitigate the scarcity of proficient professionals, thus promoting wider acceptance of transcatheter embolization devices and fostering positive market growth.
Key Segments of the Transcatheter Embolization Devices Market
Type Overview
• Embolization Coils
• Coiling-assist Devices
• Embolization Particles
• Flow Diverter Devices
• Liquid Embolics
• Accessories
Application Overview
• Peripheral Vascular Disease
• Neurology
• Oncology
• Urology
Material Overview
• Particle embolic
• Coil embolic
• Liquid embolic
• Others
Coil Type Overview
• Pushable
• Detachable
End-User Overview
• Hospitals
• Ambulatory Surgical Centers
• Clinics
Embolization Particles Type Overview
• Radioembolization Particles
• Microspheres
• Drug-eluting Beads
• Others
Regional Overview
North America
• US
• Canada
• Mexico
Europe
• Germany
• France
• U.K
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
Middle East and Africa
• Saudi Arabia
• UAE
• Rest of Middle East and Africa
Latin America
• Brazil
• Argentina
• Rest of Latin America
Frequently Asked Questions (FAQ) :
The application of the transcatheter embolization devices market Peripheral Vascular Disease, Neurology, Oncology, Urology
The transcatheter embolization devices market is growing at a CAGR of XX% over the forecast period.
The top companies that hold the market share in transcatheter embolization devices market are Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Stryker Corporation, Johnson & Johnson, Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., BTG International Ltd., and Abbott Laboratories.